US Patent Issued to Fidia Farmaceutici on April 21 for "HA-paclitaxel conjugate for treatment of mesothelioma" (Italian Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,355, issued on April 21, was assigned to Fidia Farmaceutici S.p.A. (Abano Terme, Italy).

"HA-paclitaxel conjugate for treatment of mesothelioma" was invented by Carlo Pizzocaro (Abano Terme, Italy) and Antonio Rosato (Abano Terme, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "HA-paclitaxel conjugate for use in the loco-regional treatment of the mesothelioma, i.e., the malignant pleural mesothelioma, pericardial mesothelioma and peritoneal mesothelioma, preferably malignant pleural mesothelioma, and relative pharmaceutical compositions are described."

The patent was filed on April 7, 2021, under Application No. 17/916,645.

*For further info...